Medicus Sciences Acquisition Corp. Logo

Medicus Sciences Acquisition Corp.

MSAC

(2.0)
Stock Price

10,17 USD

2.03% ROA

4.45% ROE

55.34x PER

Market Cap.

0,00 USD

0% DER

0% Yield

0% NPM

Medicus Sciences Acquisition Corp. Stock Analysis

Medicus Sciences Acquisition Corp. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Medicus Sciences Acquisition Corp. Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (0%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 ROE

ROE in an average range (10.1%) suggests satisfactory profitability and decent utilization of shareholders' equity.

3 ROA

The stock's ROA (9.6%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.

4 PBV

The stock's PBV ratio (1.32x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

5 Revenue Growth

With a track record of continuous revenue growth in the last three years, this company offers a promising investment opportunity

6 Net Profit Growth

This company's net profit has consistently grown over the past three years, showcasing a positive financial trend and making it an appealing investment opportunity.

7 Graham Number

Based on the Graham number, this company's stock price appears to be lower than its intrinsic value, signaling a potentially favorable investment choice.

8 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

9 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

10 Dividend

The company's decision to withhold dividends for three years raises questions about its ability to generate consistent returns.

11 Buffet Intrinsic Value

The company's stock presents a potential concern as it appears overvalued (0) by Warren Buffett's formula, indicating that its market price exceeds its estimated intrinsic value.

Medicus Sciences Acquisition Corp. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Medicus Sciences Acquisition Corp. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Sell
2 MACD Buy
3 RSI Buy
4 Stoch RSI Sell

Medicus Sciences Acquisition Corp. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Medicus Sciences Acquisition Corp. Revenue
Year Revenue Growth
2021 0
2022 0 0%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Medicus Sciences Acquisition Corp. Research and Development Expenses
Year Research and Development Expenses Growth
2021 0
2022 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Medicus Sciences Acquisition Corp. General and Administrative Expenses
Year General and Administrative Expenses Growth
2021 614.675
2022 696.504 11.75%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Medicus Sciences Acquisition Corp. EBITDA
Year EBITDA Growth
2021 -3.118.642
2022 -1.700.808 -83.36%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Medicus Sciences Acquisition Corp. Gross Profit
Year Gross Profit Growth
2021 -614.675
2022 -696.504 11.75%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Medicus Sciences Acquisition Corp. Net Profit
Year Net Profit Growth
2021 1.897.877
2022 3.759.128 49.51%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Medicus Sciences Acquisition Corp. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2021 0
2022 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Medicus Sciences Acquisition Corp. Free Cashflow
Year Free Cashflow Growth
2021 -798.519
2022 -88.758 -799.66%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Medicus Sciences Acquisition Corp. Operating Cashflow
Year Operating Cashflow Growth
2021 -798.519
2022 -88.758 -799.66%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Medicus Sciences Acquisition Corp. Capital Expenditure
Year Capital Expenditure Growth
2021 0
2022 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Medicus Sciences Acquisition Corp. Equity
Year Equity Growth
2020 18.932
2021 85.357.093 99.98%
2022 89.562.134 4.7%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Medicus Sciences Acquisition Corp. Assets
Year Assets Growth
2020 129.186
2021 93.624.429 99.86%
2022 93.431.852 -0.21%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Medicus Sciences Acquisition Corp. Liabilities
Year Liabilities Growth
2020 110.254
2021 8.267.336 98.67%
2022 3.869.718 -113.64%

Medicus Sciences Acquisition Corp. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
0.18
Price to Earning Ratio
55.34x
Price To Sales Ratio
0x
POCF Ratio
-131.52
PFCF Ratio
0
Price to Book Ratio
1.23
EV to Sales
0
EV Over EBITDA
0.46
EV to Operating CashFlow
1.8
EV to FreeCashFlow
1.8
Earnings Yield
0.02
FreeCashFlow Yield
0
Market Cap
0,00 Bil.
Enterprise Value
0,00 Bil.
Graham Number
5.85
Graham NetNet
-0.66

Income Statement Metrics

Net Income per Share
0.18
Income Quality
-0.42
ROE
0.04
Return On Assets
0.02
Return On Capital Employed
-0.01
Net Income per EBT
1
EBT Per Ebit
-3.09
Ebit per Revenue
0
Effective Tax Rate
-0

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0
Operating Profit Margin
0
Pretax Profit Margin
0
Net Profit Margin
0

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.08
Free CashFlow per Share
-0.08
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
-0.01
Return on Tangible Assets
0.02
Days Sales Outstanding
0
Days Payables Outstanding
0
Days of Inventory on Hand
-0.07
Receivables Turnover
0
Payables Turnover
0
Inventory Turnover
-5209.11
Capex per Share
0

Balance Sheet

Cash per Share
0,14
Book Value per Share
8,27
Tangible Book Value per Share
8.27
Shareholders Equity per Share
8.27
Interest Debt per Share
0
Debt to Equity
0
Debt to Assets
0
Net Debt to EBITDA
0.46
Current Ratio
49.36
Tangible Asset Value
0,09 Bil.
Net Current Asset Value
-0,01 Bil.
Invested Capital
0
Working Capital
0,00 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
-59
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Medicus Sciences Acquisition Corp. Dividends
Year Dividends Growth

Medicus Sciences Acquisition Corp. Profile

About Medicus Sciences Acquisition Corp.

Medicus Sciences Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It focuses on the healthcare industry primarily the medical technology sector in the United States and internationally. The company was incorporated in 2020 and is based in New York, New York.

CEO
Dr. Jacob Jay Gottlieb C.F.A.,
Employee
0
Address
152 West 57th Street
New York, 10019

Medicus Sciences Acquisition Corp. Executives & BODs

Medicus Sciences Acquisition Corp. Executives & BODs
# Name Age
1 Dr. Neil Puri M.B.A., M.D.
Chief Bus. Officer
70
2 Dr. Michael Bernard Castor M.D.
Chief Executive Officer & Director
70
3 Dr. Jacob Jay Gottlieb C.F.A., CFA, M.D.
Executive Chairman
70
4 Dr. Judah Zvi Drillick CPA
Chief Financial Officer
70

Medicus Sciences Acquisition Corp. Competitors